Riskpilot← Back to searchSign inGet full accessMULTI BIOPSY INSTRUMENTS ApS
APSDissolvedCVR 33392079Villingebækvej 73Manufacture of irradiation, electromedical and electrotherapeutic equipment · NACE 2660Est. 2011— employees
Revenue 2022
DKK 2K
-120% vs 2021
EBITDA margin
100.0%
+122% vs 2021
Equity ratio
100.0%
Financial strength
Net profit 2022
DKK 2K
+119% vs 2021
| Revenue | DKK 2K | -120% |
| EBITDA | DKK 2K | +122% |
| Net profit | DKK 2K | +119% |
| Total assets | DKK 5 | +0% |
| Equity | DKK 5 | +100% |
| Employees | — | — |
Legal name
MULTI BIOPSY INSTRUMENTS ApS
CVR number
33392079
Legal form
Anpartsselskab
NACE code
2660 · Manufacture of irradiation, electromedical and electrotherapeutic equipment
Founded
19. januar 2011
Share capital
DKK 93.520
Employees
—
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af 1 direktør
Address
Villingebækvej 73
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -65 | -41 | -65 | -27 | — | -71 | -12 | -9 | -18 | -11 | 2 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -65 | -41 | -65 | -27 | 0 | -71 | -12 | -9 | -18 | -10 | 2 |
| Depreciation & amort. | -30 | -30 | -20 | -0 | -0 | -2.115 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -95 | -71 | -85 | -27 | 0 | -2.185 | -12 | -9 | -18 | -10 | 2 |
| Net financials | -24 | 0 | 0 | -0 | 0 | 0 | 0 | -2 | -0 | -1 | 0 |
| Profit before tax | -119 | -71 | -85 | -27 | 0 | -2.185 | -12 | -11 | -18 | -12 | 2 |
| Tax | -0 | -0 | -74 | -5 | -26 | -204 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -119 | -71 | -11 | -23 | 26 | -1.982 | -12 | -11 | -18 | -12 | 2 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 682 | 2.341 | 2.397 | 2.311 | 2.313 | 114 | 17 | 0 | 4 | 0 | 0 |
| Equity | 11 | -110 | 1.637 | 1.614 | 1.620 | -362 | -374 | -385 | -403 | -415 | 0 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 670 | 2.451 | 648 | 493 | 490 | 476 | 391 | 385 | 408 | 415 | 0 |
| Total debt | 670 | 2.451 | 648 | 493 | 490 | 476 | 391 | 385 | 408 | 415 | 0 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122022
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20122022
Return on equity
45280.0%
This company
18.4%
Market median
+245987% vs market
20122022
Net profit margin
100.6%
This company
8.1%
Market median
+1142% vs market
20122022
Asset turnover
450.00×
This company
1.12×
Market median
+40079% vs market
20122022
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20122022
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-01-19 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BA Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
KM Management | Management | 2011 | — | — |
SL Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
JT Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2013 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 5.0% | 5.0% | 2013 | |
OPTIMA DENMARK ApS | Company | 10.0% | 10.0% | 2013 |
HAUERBERG HOLDING ApS | Company | 66.7% | 66.7% | 2021 |
MULTI BIOPSY INSTRUMENTS ApS | Company | 10.0% | 10.0% | 2013 |
BUGATTI ApS | Company | 66.7% | 66.7% | 2018 |
MMM INTERNATIONAL ApS | Company | 33.3% | 33.3% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MULTI BIOPSY INSTRUMENTS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bernt Anker Clausen | Chief Executive Officer | 0 companies |
| Kaj Max Nielsen | Management | 0 companies |
| Svend Leon Endresen | Chief Executive Officer | 0 companies |
| Jytte Trine Hauerberg | Chief Executive Officer | 0 companies |
| Bente Kruse Nielsen | Board of Directors | 0 companies |
| Steen Riber | Board of Directors | 0 companies |
| Søren Hauerberg | Board of Directors | 0 companies |
| Christian Dollerup Jensen | Board of Directors | 0 companies |
| Henrik Heering | Board of Directors | 0 companies |